✦ LIBER ✦

Inactivated yellow fever 17D vaccine: Development and nonclinical safety, immunogenicity and protective activity

✍ Scribed by Thomas P. Monath; Cynthia K. Lee; Justin G. Julander; Alicja Brown; David W. Beasley; Douglas M. Watts; Edward Hayman; Patrick Guertin; Joseph Makowiecki; Joseph Crowell; Philip Levesque; Gavin C. Bowick; Merribeth Morin; Elizabeth Fowler; Dennis W. Trent

Book ID: 116962545
Publisher: Elsevier Science
Year: 2010
Tongue: English
Weight: 704 KB
Volume: 28
Category: Article
ISSN: 0264-410X
DOI: 10.1016/j.vaccine.2010.03.023

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Human antibody response to immunization

Human antibody response to immunization with 17D yellow fever and inactivated TBE vaccine

✍ M. Kayser; H. Klein; I. Paasch; J. Pilaski; H. Blenk; K. Heeg 📂 Article 📅 1985 🏛 John Wiley and Sons 🌐 English ⚖ 660 KB

The antibody response against flaviviruses tick-borne encephalitis (TBE), Kyasanur Forest disease (KFD), Murray Valley encephalitis (MVE), West Nile fever (WNF), Japanese B encephalitis (JE), dengue 2 (DEN-2), and yellow fever (YF) was studied in humans after administration of an inactivated TBE vir

Immunogenicity and safety of an inactiva

Immunogenicity and safety of an inactivated Rift Valley fever vaccine in a 19-year study

✍ Janice M. Rusnak; Paul Gibbs; Ellen Boudreau; Denise P. Clizbe; Phillip Pittman 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 396 KB

Immunogenicity, safety, and protective e

Immunogenicity, safety, and protective efficacy of an inactivated SARS-associated coronavirus vaccine in rhesus monkeys

✍ Jun Zhou; Wei Wang; Qiong Zhong; Wei Hou; Zhanqiu Yang; Shu-Yuan Xiao; Runqing Z 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 277 KB

Immunogenicity and protective efficacy o

Immunogenicity and protective efficacy of a recombinant yellow fever vaccine against the murine malarial parasite Plasmodium yoelii

✍ Cristina T. Stoyanov; Silvia B. Boscardin; Stephanie Deroubaix; Giovanna Barba-S 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 981 KB

Safety and protective efficacy of INA-in

Safety and protective efficacy of INA-inactivated Venezuelan equine encephalitis virus: Implication in vaccine development

✍ Anuj Sharma; Paridhi Gupta; Pamela J. Glass; Michael D. Parker; Radha K. Maheshw 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 612 KB

Active and passive surveillance of yello

Active and passive surveillance of yellow fever vaccine 17D or 17DD-associated serious adverse events: Systematic review

✍ Roger E. Thomas; Diane L. Lorenzetti; Wendy Spragins; Dave Jackson; Tyler Willia 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 423 KB